. Author manuscript; available in PMC: 2019 Sep 6.

Published in final edited form as: Pediatr Nephrol. 2018 Dec 19;34(5):865–871. doi: 10.1007/s00467-018-4178-x

Table 2.

Patient demographics of patients who developed TMA and controls without TMA

	TMA (n=13)	Controls (n = 3)
Age in years	9.3 (0.6–18.7)	17.0 (7.1–27.8)
Males	8 (61%)	2 (67%)
Caucasians	8 (61%)	2 (67%)
Donor unrelated	11 (85%)	2 (67%)
HLA full match	9 (69%)	3 (100%)
Myeloablative conditioning regimen	7 (54%)	2 (67%)
Time to TMA diagnosis from baseline (days ± SD)	47 (±21)	N/A

TMA thrombotic microangiopathy